A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...

Charlotte native Donna White's journey with bioidentical hormone replacement therapy began more than 30 years ago. White, now ...

Xeris is a growth-oriented biopharmaceutical company committed to improving ... a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a proven therapy for primary ...

Telix has also provided R&D expenditure guidance, expecting an increased investment range of 20% to 25% compared to FY2024. An investor webcast will be held at 9.00am AEDT on Friday 21 February 2025 ...

USA News Group News CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Feb. 19, 2025 /PRNewswire/ -- USA News Group News Commentary - Amid the excitement surrounding ...

Issued on behalf of Oncolytics Biotech Inc. "We're hitting critical milestones that validate our progress and set the stage for what we believe will be an exciting year," said Wayne Pisano, Interim ...

Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...

Expert Aisha Ahmed Co-Author Book Showcasing Neuroscience and Quantum Energetics for Lasting ChangeOntario, Canada, February ...

If you’re willing to invest in the prep work, this therapy service can be a valuable resource for personal growth.” John Murray tested Online-Therapy.com for several weeks. While he found the ...

Growth stocks rebounded in 2023 and 2024, outperforming the general market. High inflation and economic factors can depress growth stock returns and increase their risk. Growth stocks show ...